Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

666
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
666
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

302
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
302
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

522
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
522
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

687
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
687
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

574
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
574
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

1.1K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

WABIP/AABIP statement on therapeutic indications of medical thoracoscopy for benign pleural disease.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Optimal Number of Pleural Biopsies During Pleuroscopy (OPTIBIOP).

Journal of bronchology & interventional pulmonology·2026
Same author

Placebo versus Erector Spinae Plane Block for Medical Thoracoscopy Study (PAINLESS).

Respiration; international review of thoracic diseases·2026
Same author

Comparative efficacy of on-demand Sildenafil, Tadalafil and daily Tadalafil for treatment of erectile dysfunction: A 12-week randomized controlled study.

Indian journal of psychiatry·2026
Same author

Response to 'A Mechanistic and Morphologic Approach to Managing Benign Central Airway Obstruction'.

Respirology (Carlton, Vic.)·2025
Same author

American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series: Update on Curative-Intent Bronchoscopy for Centrally Located Early-Stage Lung Cancer.

Journal of bronchology & interventional pulmonology·2025

Related Experiment Video

Updated: Mar 14, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K

Endocarditis in left ventricular assist device.

Braghadheeswar Thyagarajan1, Monisha Priyadarshini Kumar2, Rutuja R Sikachi3

  • 1Department of Medicine, Monmouth Medical Center, Long Branch, New Jersey, USA.

Intractable & Rare Diseases Research
|September 28, 2016
PubMed
Summary

Infections, particularly endocarditis, are serious complications for patients with left ventricular assist devices (LVADs). Bacterial and fungal endocarditis in LVAD patients lead to high rates of illness and death.

Keywords:
Endocarditisleft ventricular assist device (LVAD)

More Related Videos

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.3K
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
05:18

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

125

Related Experiment Videos

Last Updated: Mar 14, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.3K
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
05:18

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

125

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Medical Device Technology

Background:

  • Heart failure is a leading cause of death globally.
  • Left ventricular assist devices (LVADs) are crucial for advanced heart failure management.
  • LVAD infections, especially endocarditis, present significant challenges.

Purpose of the Study:

  • To review risk factors, causative organisms, diagnostics, and management of LVAD-associated endocarditis.
  • To analyze complications and outcomes in patients with LVAD endocarditis.
  • To consolidate current knowledge on this rare but severe complication.

Main Methods:

  • Comprehensive literature review of endocarditis secondary to LVAD placement.
  • Analysis of retrospective studies and case reports.
  • Synthesis of data on risk factors, pathogens, and treatment strategies.

Main Results:

  • Bacterial infections are the most common cause of endocarditis in LVAD patients.
  • Both bacterial and fungal endocarditis are associated with high morbidity and mortality.
  • Limited studies currently exist, highlighting a need for further research.

Conclusions:

  • LVAD endocarditis is a severe complication requiring prompt diagnosis and management.
  • Understanding risk factors and causative organisms is key to improving patient outcomes.
  • Further research is needed to optimize treatment and reduce mortality associated with LVAD endocarditis.